NSF Webinar: Hemp and CBD Product and Facility Certification
NSF’s technical and scientific experts have developed a pathway for hemp/CBD product brands to reach certification that meets established standards.
NSF developed the American National Standard for testing and certifying dietary supplements, and now offers certification for hemp and CBD manufacturing facilities and products. NSF technical and business development experts created this webinar to help you understand the process and prepare for success.
Did you know:
- Hemp and CBD manufacturers are eligible for NSF/ANSI/455 certification for both dietary supplements and cosmetic products
- Hemp and CBD products are eligible for both NSF/ANSI 173 Contents Certified product certification and NSF’s exclusive Certified for Sport® certification
Start your certification process by learning the basics from this expert webinar, which includes:
- Definitions
- Public health and safety standards
- Comparing hemp extracts
- Certification eligibility
- Product label criteria
Ready to Learn More About Hemp and CBD Certification?
Contact us with questions or to request a quote.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
2024 GFSI Conference - Meeting the Needs of our Evolving World
March 20, 2024NSF is proud to announce our sponsorship of the GFSI Conference, an annual event dedicated to advancing food safety and consumer trust.
Read the Story
NSF Acquires PSILab, Inc., an Advanced Plastic Pipe and Materials Testing Laboratory
March 18, 2024The acquisition extends NSF’s service offerings in the water industry, furthering its commitment to the quality, performance and safety of water products globally.
Read the Story
Dwayne “The Rock” Johnson’s ZOA+ Powder Earns NSF Certified for Sport® Certification
March 4, 2024New Pre-Workout Powder Joins Elite Group of NSF Certified For Sport® Dietary Supplements.
Read the Story
February 2024 Pharma News Update
February 15, 2024The February 2024 update looks at the FDA’s guidance on conducting remote regulatory assessments and more.
Read the Story